tiprankstipranks

10x Genomics price target lowered to $50 from $65 at Canaccord

Canaccord analyst Kyle Mikson lowered the firm’s price target on 10x Genomics to $50 from $65 and keeps a Buy rating on the shares. The firm believes the recent selloff has provided an attractive opportunity to accumulate shares of the company with potential catalysts and notes management could share updates related to their strategies for targeting focused markets.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue